Benchmark Holdings plc 

("Benchmark", the "Company" or the "Group")

Notice of Q1 Results

Webcast for analysts and institutional investors
Equity Development webcast for retail investors

Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK), the aquaculture
biotechnology business, will announce its Q1 results, for the three month period
ended 31 December 2023, on Thursday 15 February 2024. 

Presentation for analysts and institutional investors at 9.30am GMT

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host a presentation for analysts and institutional investors on the
day at 09.30 GMT (10.30 CET). 

The presentation will be held in person at Haakon Vlls Gate 2, Oslo, Norway. To
register your interest, please contact benchmark@mhpgroup.com 

A live webcast of the presentation will be available for analysts and investors
to join remotely at the following link:
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20240215_10

Equity Development webcast for retail investors at 12:00pm UK time

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host a second webcast for retail investors and wealth managers at
12.00pm UK time. The webcast is open to all existing and potential shareholders.


To register please visit:
https://www.equitydevelopment.co.uk/news-and-events/benchmark-q1-investor-presen
tation-15february2024


  Enquiries
For further information, please contact:	
Benchmark Holdings plc	Tel:  0114 240 9939
Trond Williksen, CEO	
Septima Maguire, CFO	
Ivonne Cantu, Investor Relations	
	
	
Deutsche Numis (Broker and NOMAD)	Tel:  020 7260 1000
Freddie Barnfield, Duncan Monteith, Sher Shah	
	
MHP 	Tel:  020 3128 8100
Katie Hunt, Reg Hoare	benchmark@mhpgroup.com 


Equity Development
Hannah Crowe	
Tel:  020 7065 2692
	


About Benchmark
Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is
to enable aquaculture producers to improve their sustainability and
profitability.
We bring together biology and technology to develop innovative products and
solutions which improve yield, quality and animal health and welfare for our
customers. We do this by improving the genetic make-up, health and nutrition of
their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon
eggs, live feed (Artemia), specialist diets and probiotics and sea lice
treatments. Find out more at www.benchmarkplc.com.